TrialAdvances in therapy2024

Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials.

Takayuki Hamano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.